SINO-OCEAN GP(03377): The hearing for the UK restructuring plan application has ended, and the court will reserve judgment on the outcome.
Ocean Group (03377) announced that its application for approval of the UK restructuring plan will be sought from January 15, 2025...
SINO-OCEAN GP (03377) announced that it is seeking approval for its restructuring plan in the UK. A hearing for the application will be held from January 15th to 20th, 2025. The English court reserves the right to make a judgment.
Related Articles

Increasing presence in the US market: Astrazeneca PLC Sponsored ADR (AZN.US) listing on the New York Stock Exchange, London position may be weakened.

SHUN WO GROUP (01591) issued 133 million shares under the "3-for-1" benchmark distribution.

Shaanxi Panlong Pharmaceutical (002864.SZ): Fluibuprofen patch approved for clinical trials.
Increasing presence in the US market: Astrazeneca PLC Sponsored ADR (AZN.US) listing on the New York Stock Exchange, London position may be weakened.

SHUN WO GROUP (01591) issued 133 million shares under the "3-for-1" benchmark distribution.

Shaanxi Panlong Pharmaceutical (002864.SZ): Fluibuprofen patch approved for clinical trials.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


